Global Breast Cancer Clinical Trial Pipeline Highlights Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Breast Cancer Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides the most up-to-date information on key pipeline products in the global Breast Cancer market. It covers emerging therapies for Breast Cancer in active clinical development stages including early and late stage clinical trials. The … [Read more…]

Peptide Therapeutics Market Intelligence by API, Drug Class, Technology, Application, End-user, Region – Global Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Peptide Therapeutics Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Peptide Therapeutics Market is projected to reach USD 50.72 billion by 2027 from USD 27.13 billion in 2021, at a CAGR 10.99% during the forecast period. In this report, the years 2019 and 2020 … [Read more…]

BioAge Partners With Age Labs to Decipher Healthy Longevity Using Samples and Data From a Preeminent Northern European Biobank

Company will analyze longitudinal biological samples and clinical data to identify molecular pathways associated with healthy longevity, leading to development of drug targets for diseases of aging RICHMOND, Calif.–(BUSINESS WIRE)–#aging–BioAge Labs, Inc. (“BioAge”, “the Company”), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that … [Read more…]

Chungcheongbuk-do Province Hosts 2022 CHUNGBUK BEST PRODUCT PROMOTION to Develop the Indonesian Market for Promising Export Companies in the Province

From August 26th to 28th, 30 Korean companies exhibit and sell their excellent products in Jakarta, Indonesia CHEONGJU, South Korea & JAKARTA, Indonesia–(BUSINESS WIRE)–#2022ChungbukBestProductPromotion–Chungcheongbuk-do has started to secure export channels for promising exporters in North Chungcheong Province to the Indonesian market. 2022 CHUNGBUK BEST PRODUCT PROMOTION will be held by Chungcheongbuk-do and Chungbuk Business Agency … [Read more…]

AdvanCell Closes A$18M Series B Funding Led by Morningside

Series B financing will accelerate growth and advance lead clinical program 212Pb-ADVC001 a best-in-class treatment for metastatic prostate cancer, expand manufacturing platform footprint and progress internal and partnership programs. SYDNEY–(BUSINESS WIRE)–#AdvanCell–AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 … [Read more…]

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CCR8 Monoclonal Antibody CM369

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM369, an anti-CC chemokine receptor 8 (CCR8) monoclonal antibody, developed by a joint venture between the two companies called Tiannuojiancheng Pharma, has been approved by the China’s National Medical Products Administration (NMPA). CM369 is a … [Read more…]

GC Biopharma to Present New Data on Trends in Varicella Incidence Cases with Complications Among Korean Children at the 2022 ICPE

– Cases of Varicella infections have fallen by 92% in 10 years – Studies implies that the one-dose universal varicella vaccination program in Korea since 2005 has been successful in preventing chickenpox YONGIN, South Korea–(BUSINESS WIRE)–GC Biopharma (006280.KS) today announced that it will present new data demonstrating trends in the incidence of varicella cases with … [Read more…]

Babylon Appoints David Humphreys as Chief Financial Officer

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE:BBLN) (“Babylon” or the “Company”), one of the world’s fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company’s new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for … [Read more…]

Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City. Anebulo’s … [Read more…]

Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health

Transaction Expands Labcorp’s Footprint with New Jersey’s leading academic health system BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey’s largest academic health system. “The communities, physicians and health systems … [Read more…]